Health & Biotech
Apiam Animal Health (ASX:AHX) is comprised of Australia’s leading Production Animal and Mixed Animal veterinary practices.
Apiam Animal Health incorporates over 150 highly experienced, industry leading veterinarians with expertise across pig, dairy, feedlot, sheep, poultry, equine, and companion animal sectors, supported by an experienced administration, nursing, technical services and ancillary team.
Apiam Animal Health is fully vertically integrated, including having veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.
What sets Apiam apart is shared expertise and professional collaboration across the business.
We believe that local knowledge is global knowledge and apply this philosophy across all our businesses from vet clinic, to production animal consultancy, logistics and laboratory with our vets and allied staff sharing expertise and specialist knowledge.
We collaborate and consult across Apiam businesses to deliver the best outcomes for the animals in our care. We are focussed on meeting the needs of our clients and shaping the future of the industry to deliver best practice animal welfare at a local level and nationally.
The name Apiam Animal Health and the logo for the company were inspired by the honey bee, which belongs to the Genus Apis.
Bees are symbolic of a team working towards a common goal. They are seen as industrious, hard-working characteristics: creating wonderfully efficient, meticulous, hexagonal hives.
Hexagons form a repetitive pattern, common in nature due to scalability while maintaining their robustness and strength.
It is Apiam Animal Health’s goal that all clinics, businesses and employee’s will work together towards a common goal, developing its team and building a successful, inspiring and strong company.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Dairy and mixed clinics boost Apiam FY21 profits as the vet network continues regional expansion
News
ASX Small Cap Lunch Wrap: Who wasn’t invited to the party today?
Health & Biotech
More resources, better vets, booming profits; How Apiam is changing the game with Australia’s largest regional vet network
Health & Biotech
Apiam is staying busy in M&A as it builds a dominant regional vet network – here’s how the numbers stack up
Experts
MoneyTalks: Which ASX stocks might be the next takeover targets? Here’s one fundie’s view
Health & Biotech
Apiam expands equine footprint and boosts Qld growth network with new acquisition, shares climb
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
Apiam delivers major boost for Australia’s $5bn pork industry with Data Pig technology platform
Health & Biotech
Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics
Health & Biotech
Apiam expands dominant footprint in regional markets with major Queensland acquisition
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
The federal government just prioritised vets on its skilled migrant list – here’s why Apiam is set to be a major beneficiary
Health & Biotech
Apiam gains traction with analysts, institutional investors and strategic partners as regional growth plans accelerate
News
Seachange? The growth opportunities for ASX stocks in Australia’s booming regional corridors
Health & Biotech
Big investors pile in to Apiam’s $6m funding round as its regional growth strategy accelerates
Health & Biotech
Apiam shares are up more than 30pc in 2021, as corporate investors back its aggressive growth strategy
Health & Biotech